SciELO - Scientific Electronic Library Online

 
vol.112 número2Infección grave por Staphylococcus aureus en tres unidades de cuidados intensivos pediátricos: análisis de los casos de neumonía necrotizante índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Archivos argentinos de pediatría

versión impresa ISSN 0325-0075

Resumen

BANCALARI M, Aldo; SCHADE Y, Ricardo; PENA Z, Rubén  y  PAVEZ P, Nicolás. Intravitreal bevacizumab as single drug therapy for retinopathy of prematurity in 12 patients. Arch. argent. pediatr. [online]. 2014, vol.112, n.2, pp.160-163. ISSN 0325-0075.  http://dx.doi.org/10.5546/aap.2014.160.

Ophthalmological outcomes in a series ofchildrenwithretinopathy ofprematurity (ROP) in the threshold stage treated withintravitreal bevacizumab are reported. Twelve very low birth weight (VLBW) preterm infants who were administered intravitreal bevacizumab as monotherapy for retinopathy of prematurity in the threshold stage and in whom standard laser photocoagulationtherapy was contraindicatedwere evaluated. Ophthalmological examinations were carried out and response to treatment, second interventions, and complications were evaluated. The gestational age of these patients was 26.3 ± 1.8 weeks and their birth weight was 845 ± 153 g. A good response was observed in eight cases, while four patients required to be reintervened with laser photocoagulation. No immediate complications were detected and there were no deaths.

Palabras clave : Retinopathy of prematurity; Intravitreal injections; Bevacizumab.

        · resumen en Español     · texto en Español     · Español ( pdf ) | Inglés ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons